Terms: = Bone cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
69 results:
1. Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia.
Wang G; Yan G; Sang K; Yang H; Sun N; Bai Y; Xu F; Zheng X; Chen Z
BMC Cancer; 2022 May; 22(1):481. PubMed ID: 35501730
[TBL] [Abstract] [Full Text] [Related]
2. Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Advanced cancer Patients: Influence of Demographic and Clinical Factors.
Karas S; Mathijssen RHJ; van Schaik RHN; Forrest A; Wiltshire T; Innocenti F; Bies RR
Clin Pharmacol Ther; 2022 Aug; 112(2):316-326. PubMed ID: 35467016
[TBL] [Abstract] [Full Text] [Related]
3. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
Rubinstein JD; Jodele S; Heyenbruch D; Wilhelm J; Thomas S; Lutzko C; Zhu X; Leemhuis T; Cancelas JA; Keller M; Bollard CM; Hanley PJ; Boghdadly ZE; Mims A; Davies SM; Grimley MS; Nelson AS
Transplant Cell Ther; 2022 Feb; 28(2):116.e1-116.e7. PubMed ID: 34785398
[TBL] [Abstract] [Full Text] [Related]
4. Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.
King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
[TBL] [Abstract] [Full Text] [Related]
5. [Therapy-related acute promyelocytic leukemia developing during chemotherapy for thymic carcinoma].
Amino I; Maeda T; Aoki M; Kinoshita H; Muroya A; Taji Y; Kobayashi K; Okamura D; Murayama Y; Asou N; Ebihara Y
Rinsho Ketsueki; 2020; 61(8):874-878. PubMed ID: 32908049
[TBL] [Abstract] [Full Text] [Related]
6. Successful treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
[TBL] [Abstract] [Full Text] [Related]
7. miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia.
Bai Y; Chen C; Guo X; Ding T; Yang X; Yu J; Yang J; Ruan J; Zheng X; Chen Z
Cancer Biomark; 2020; 29(1):125-137. PubMed ID: 32568176
[TBL] [Abstract] [Full Text] [Related]
8. Identification of a new cryptic pml-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH.
Zhang Z; Xu Y; Jiang M; Kong F; Chen Z; Liu S; Li F
Cancer Biol Ther; 2020 Apr; 21(4):309-314. PubMed ID: 31959056
[TBL] [Abstract] [Full Text] [Related]
9. The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study.
Ronsley R; Kariminia A; Ng B; Mostafavi S; Reid G; Subrt P; Hijiya N; Schultz KR
Pediatr Hematol Oncol; 2019 Nov; 36(8):468-481. PubMed ID: 31530240
[No Abstract] [Full Text] [Related]
10. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
[TBL] [Abstract] [Full Text] [Related]
11. Role of minimal residual disease in the management of acute myeloid leukemia-a case-based discussion.
Coltoff A; Houldsworth J; Keyzner A; Renteria AS; Mascarenhas J
Ann Hematol; 2018 Jul; 97(7):1155-1167. PubMed ID: 29704019
[TBL] [Abstract] [Full Text] [Related]
12. [Transformation from promyelocytic leukemia with t (15; 17) ( q22; q21) to acute monocytic leukemia with t (11; 17) (q23; q21) in a case].
Wang Z; Li Y; Dang H; Shi Y; He Q; Feng L; Bao L; Qin Y; Liu Y; Huang X; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):276-279. PubMed ID: 29653010
[TBL] [Abstract] [Full Text] [Related]
13. Induction of senescence in primary glioblastoma cells by serum and TGFβ.
Kumar R; Gont A; Perkins TJ; Hanson JEL; Lorimer IAJ
Sci Rep; 2017 May; 7(1):2156. PubMed ID: 28526854
[TBL] [Abstract] [Full Text] [Related]
14. [Acute Promyelocytic Leukemia Developed during Imatinib Therapy for Gastrointestinal Stromal Tumors].
Yu YP; Song P; Mei JG; An ZM; Zhou XG; Li F; Wang LP; Tang YM; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):358-364. PubMed ID: 28446275
[TBL] [Abstract] [Full Text] [Related]
15. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
Noguera NI; Pelosi E; Angelini DF; Piredda ML; Guerrera G; Piras E; Battistini L; Massai L; Berardi A; Catalano G; Cicconi L; Castelli G; D'Angiò A; Pasquini L; Graziani G; Fioritoni G; Voso MT; Mastrangelo D; Testa U; Lo-Coco F
Oncotarget; 2017 May; 8(20):32550-32565. PubMed ID: 28427227
[TBL] [Abstract] [Full Text] [Related]
16. Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
Tang YL; Chia WK; Yap EC; Julia MI; Leong CF; Salwati S; Wong CL
Malays J Pathol; 2016 Dec; 38(3):315-319. PubMed ID: 28028303
[TBL] [Abstract] [Full Text] [Related]
17. RARα2 and pml-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract] [Full Text] [Related]
18. Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells.
El Hajj H; Dassouki Z; Berthier C; Raffoux E; Ades L; Legrand O; Hleihel R; Sahin U; Tawil N; Salameh A; Zibara K; Darwiche N; Mohty M; Dombret H; Fenaux P; de Thé H; Bazarbachi A
Blood; 2015 May; 125(22):3447-54. PubMed ID: 25800051
[TBL] [Abstract] [Full Text] [Related]
19. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
[TBL] [Abstract] [Full Text] [Related]
20. Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukemia (APL).
Kolhe R; Mangaonkar A; Mansour J; Clemmons A; Shaw J; Dupont B; Walczak L; Mondal A; Rojiani A; Jillella A; Kota V
Int J Lab Hematol; 2015 Aug; 37(4):515-20. PubMed ID: 25639817
[TBL] [Abstract] [Full Text] [Related]
[Next]
